» Articles » PMID: 26043732

Variation in Lung Cancer Resources and Workload: Results from the First National Lung Cancer Organisational Audit

Overview
Journal Thorax
Date 2015 Jun 6
PMID 26043732
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We report the findings of the first national lung cancer organisational audit. The results demonstrate marked variation in service provision and workload of some lung cancer specialists. For example, over half of the clinical nurse specialists report case volumes over recommended numbers. Some trusts have no access to key treatments such as video assisted thoracoscopy (VAT) lobectomy and stereotactic radiotherapy. Multivariate regression analysis demonstrated an association between higher surgical resection rates and the on-site availability of advanced staging and therapeutic modalities, for example, PET scan and VAT lobectomy. We conclude by making a number of recommendations to address the variation in lung cancer care.

Citing Articles

Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paper.

Smith S, Brand M, Harden S, Briggs L, Leigh L, Brims F BMJ Open. 2022; 12(8):e060907.

PMID: 36038161 PMC: 9438055. DOI: 10.1136/bmjopen-2022-060907.


Results of the Austrian National Lung Cancer Audit.

Burghuber O, Kirchbacher K, Mohn-Staudner A, Hochmair M, Breyer M, Studnicka M Clin Med Insights Oncol. 2020; 14:1179554920950548.

PMID: 32963472 PMC: 7488615. DOI: 10.1177/1179554920950548.


Implementation and outcomes of the RAPID programme: Addressing the front end of the lung cancer pathway in Manchester.

Evison M, Hewitt K, Lyons J, Crosbie P, Balata H, Gee C Clin Med (Lond). 2020; 20(4):401-405.

PMID: 32675147 PMC: 7385808. DOI: 10.7861/clinmed.2019-0218.


Understanding local performance data for EBUS-TBNA: insights from an unselected case series at a high volume UK center.

Jeebun V, Harrison R J Thorac Dis. 2017; 9(Suppl 5):S350-S362.

PMID: 28603645 PMC: 5459869. DOI: 10.21037/jtd.2017.05.18.


How should performance in EBUS mediastinal staging in lung cancer be measured?.

Evison M, Crosbie P, Navani N, Callister M, Rintoul R, Baldwin D Br J Cancer. 2016; 115(8):e9.

PMID: 27552438 PMC: 5061900. DOI: 10.1038/bjc.2016.253.